27 results

Fotolia_162908834_Subscription_Monthly_M

Posted on 15.10.2018

Looking after your sexual health

We’re fortunate to be living in a time when it’s OK to talk openly about sexual health. But with so much information out there, unpicking the facts from the myths can sometimes be tricky. UK-based sexual health charity FPA aims to educate the public about sexual and reproductive health and wellbeing, especially during our annual […]

By Bekki Burbidge Deputy Chief Executive at FPA

world hepatitis day
Getting checked

Posted on 28.07.2018

Why up to 290 million people are at risk of unknowingly developing liver disease or cancer

New research from the World Hepatitis Alliance reveals why 9 in 10 people living with viral hepatitis are unaware of their status Two years ago, 194 countries committed to the goal of eliminating viral hepatitis by 2030. By adopting the World Health Organization’s Global health sector strategy on viral hepatitis, governments finally recognised the disease […]

By Raquel Peck the CEO of the World Hepatitis Alliance (WHA)

BeFirst-banner-website-2
Chronic conditions

Posted on 07.06.2018

Why should we prevent cervical cancer? Because we can

This blog is part of the Early Diagnosis campaign #BeFirstEarly diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice. Read the other blogs here: A […]

By Dr. Ed Baker Roche Molecular diagnostics

preeclampsia
Getting checked

Posted on 22.05.2018

How can we manage preeclampsia risk during pregnancy?

Preeclampsia is a serious pregnancy disorder occurring only during pregnancy. To mark World Preeclampsia Day (May 22), I would like to share some insights on how to make pregnancy after preeclampsia as safe as possible for women and babies. One of the questions we hear most frequently from women who have experienced preeclampsia is: ‘Is […]

By Ralph Schimmer Chief Medical Officer and Head Global Medical & Scientific Affairs at Roche Diagnostics / Centralised and Point of Care Solutions

Fotolia_91294554_Subscription_Monthly_M
Global

Posted on 21.02.2017

From over-testing to over-treatment – exploring pros and cons of screening programmes

The argument has raged for some time and shows no sign of abating any time soon: screening for diseases, yes or no? Take the case of prostate cancer screening: Richard Ablin – the author of “The Great Prostate Hoax”, and the man who claims to be the first to have identified PSA (a protein created […]

By Denis Horgan Executive Director, European Alliance for Personalised Medicine

Fotolia_105340400_Subscription_Monthly_M
Global

Posted on 01.02.2017

We’re living longer – but can we live better?

Most Europeans born today will live into their eighties but behind that impressive statistic lie inequalities and ill-health. It’s time we focused on adding life to years instead of years to life. In 1990, life expectancy at birth was 74.1 years in Europe. Today, it’s 80.9. This is a remarkable achievement, by any measure. However, […]

By Gary Finnegan Health Journalist

Zika_edit
Global

Posted on 05.02.2016

Why diagnostics is important in dealing with the Zika threat

In the last few weeks we have seen the emergence of a new global public health threat, the Zika Virus (ZIKV). Both the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) are monitoring the spread of the Zika, a mosquito borne arbovirus. The WHO recently declared the diseases linked […]

By Jesús Rueda Rodríguez Director International Affairs MedTech Europe

mother_daughter3_1170-770x460
Value

Posted on 18.08.2015

Women with ovarian cancer living longer than expected

Almost one-third of California women with ovarian cancer survive at least 10 years after diagnosis. The findings upend the notion that women diagnosed with cancer of the ovary always face a poor chance of survival. In fact, while the study confirmed earlier findings on characteristics associated with ovarian cancer survival—younger age, earlier stage, and lower […]

image-20150528-31337-1kdfzft
Value

Posted on 03.06.2015

How understanding breast cancer at a molecular level is revolutionizing our thinking

The evolution of past and modern therapies in breast cancer has been an inspiring illustration of the progress that has been made towards cancer cures. Breast cancer makes up a quarter of new cases worldwide and is the most common cancer in women. While the number of people with breast cancer has been increasing fewer people are dying […]